510(k) K012960
K012960 is an FDA 510(k) premarket notification submitted by Biogenex Laboratories for the device "BIOGENEX MONOCLONAL ANTI-PROGESTERONE RECEPTOR". The FDA issued a decision of Substantially Equivalent on March 8, 2002. The device falls under product code MXZ (Immunohistochemistry Assay, Antibody, Progesterone Receptor), a Class II device regulated under 21 CFR 864.1860. Biogenex Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 8, 2002
- Date Received
- September 4, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Immunohistochemistry Assay, Antibody, Progesterone Receptor
- Device Class
- Class II
- Regulation Number
- 864.1860
- Review Panel
- PA
- Submission Type